Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gardasil and Twinrix Co-administration and HPV Booster Study
NCT01456715Phase 3Completed
- Sponsor
- Université Laval
- Start
- Sep 2008
- Primary completion
- Dec 2018
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of human papillomavirus type 16 L1 capsid protein antigen in human papillomavirus infection, sponsored by Université Laval. Started Sep 2008; status: completed.
02
Drugs
human papillomavirus type 16 L1 capsid protein antigen
03
Conditions
human papillomavirus infection
Beyond the preview
Go deeper on NCT01456715.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01456715.